Publication | Open Access

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Patients 60Antimicrobial SusceptibilityAntibioticsClostridium Difficile InfectionAntimicrobial ChemotherapyMicrobiologyInfection ControlMedicineClinical MicrobiologyAntimicrobial Resistance